Dr McGoron received his BS and MS in Biomedical Engineering from Wright State University and his PhD in Biomedical Engineering from Louisiana Tech University, where he held a Board of Regents Graduate Fellowship. He received post-doctoral training in Pharmacology and Cell Biophysics at the University of Cincinnati. Dr McGoron’s first faculty appointment was in the Department of Radiology, Divisions of Nuclear Medicine and Medical Physics at UC College of Medicine. He joined FIU in 1999 and was instrumental in the development of the academic programs in Biomedical Engineering (BME). He led the design and implementation of the BS in BME program in 2002, its initial ABET accreditation in 2005, and re-accreditation in 2008. He served as the founding Advisor for the student chapters of the Biomedical Engineering Society (BMES) and the Alpha Eta Mu Beta (AEMB) Biomedical Engineering Honor Society. He received the American Heart Initial Investigator Award in 2001. He has over 130 journal articles, book chapters and proceeding papers. He has received funding from the NIH, NSF, AHA, Fl-DOH, and DOD as well as numerous companies. In 2010 he was elected National President of AEMB. He served as the interim chair of BME at FIU from 2007-2010. The primary focus of Dr McGoron’s research is drug delivery and molecular imaging, primarily for cancer, and specifically the development of multimodal drugs that simultaneously image and provide therapy. Efforts include the development of tissue or cell specific contrast agents and probes (both optical and radioactive) for noninvasive molecular imaging of cellular and tissue characterization, for monitoring toxicity, for tracking the biodistribution of known toxins and drugs, and image guided therapy.
On-chip surface-enhanced Raman spectroscopy (SERS)-linked immuno-sensor assay (SLISA) for rapid environmental-surveillance of chemical toxins
3D dosimetry estimation for selective internal radiation therapy (SIRT) using SPECT/CT images: a phantom study
Interaction of dye-enhanced photothermotherapy and chemotherapy in the treatment of cancer: an in vitro study